연구동향 분석
박사

Topical Administration of Trichostatin A Attenuates Conjunctival Fibrosis After Glaucoma Filtration Surgery = 녹내장 수술 동물 모델에서 Trichostatin A 점안액의 결막 섬유화 억제 효과

성미선 2018년

논문상세정보
인용/피인용
' Topical Administration of Trichostatin A Attenuates Conjunctival Fibrosis After Glaucoma Filtration Surgery = 녹내장 수술 동물 모델에서 Trichostatin A 점안액의 결막 섬유화 억제 효과' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의료과학 약
  • Fibrosis
  • Histone deacetylase
  • trabeculectomy
  • trichostatin a
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
4,132 0

0.0%

' Topical Administration of Trichostatin A Attenuates Conjunctival Fibrosis After Glaucoma Filtration Surgery = 녹내장 수술 동물 모델에서 Trichostatin A 점안액의 결막 섬유화 억제 효과' 의 참고문헌

  • Yamanaka O, Saika S, Ohnishi Y, et al. Inhibition of p38MAP kinase suppresses fibrogenic reaction in conjunctiva in mice. Mol Vis 2007;13:1730-1739.
  • Yamanaka O, Ikeda K, Saika S, et al. Gene transfer of Smad7 modulates injury-induced conjunctival wound healing in mice. Mol Vis 2006;12:841-851.
  • Xie M, Hill JA. HDAC-dependent ventricular remodeling. Trends Cardiovasc Med 2013;23:229-235.
  • Wilson SL, Ahearne M, Hopkinson A. An overview of current techniques for ocular toxicity testing. Toxicology 2015;327:32-46.
  • Thiagalingam S, Cheng KH, Lee HJ, et al. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci 2003;983:84-100.
  • Taylor HR, Keeffe JE. World blindness: a 21st century perspective. Br J Ophthalmol 2001;85:261-266.
  • Shi H, Wang H, Fu S, et al. Losartan attenuates scar formation in filtering bleb after trabeculectomy. Invest Ophthalmol Vis Sci 2017;58:1478-1486.
  • Sherwood MB, Esson DW, Neelakantan A, Samuelson DA. A new model of glaucoma filtering surgery in the rat. J Glaucoma 2004;13:407-412.
  • Sharma A, Anumanthan G, Reyes M, et al. Epigenetic modification prevents excessive wound healing and scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci 2016;57:3381-3389.
  • Seibold LK, Sherwood MB, Kahook MY. Wound modulation after filtration surgery. Surv Ophthalmol 2012;57:530-550.
  • Pauly A, Brignole-Baudouin F, Labbė A, et al. New tools for the evaluation of toxic ocular surface changes in the rat. Invest Ophthalmol Vis Sci 2007;48:5473-5483.
  • Pang M, Kothapally J, Mao H, et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 2009;297:F996-1005.
  • Palanca-Capistrano AM, Hall J, Cantor LB, et al. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery. Ophthalmology 2009;116:185-190.
  • Noh H, Oh EY, Seo JY, et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol. 2009;297:F729-F739.
  • Nikita E, Moulin A, Vergados I, et al. A pilot study on ocular safety and efficacy of infliximab as an antifibrotic agent after experimental glaucoma filtration surgery. Ophthalmol Ther 2017 In press.
  • Montgomery RL, Davis CA, Potthoff MJ, et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 2007;21:1790-1802.
  • Mohamed-Ahmed AHA, Lockwood A, Li H, et al. An Ilomastat-CD eye drop formulation to treat ocular scarring. Invest Ophthalmol Vis Sci 2017;58:3425-3431.
  • Marumo T, Hishikawa K, Yoshikawa M, et al. Histone deacetylase modulates the proinflammatory and fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol 2010;298:F133-F141.
  • Liu L, Siriwardena D, Khaw PT. Australia and New Zealand survey of antimetabolite and steroid use in trabeculectomy surgery. J Glaucoma 2008;17:423-430.
  • Kitano A, Okada Y, Yamanka O, et al. Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface. Mol Vis 2010;16:2964-2973.
  • Kim MS, Kwon HJ, Lee YM, et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 2001;7:437-443.
  • Khaw PT, Chang L, Wong TT, et al. Modulation of wound healing after glaucoma surgery. Curr Opin Ophthalmol 2001;12:143-148.
  • Kee HJ, Sohn IS, Nam KI, et al. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 2006;113:51-59.
  • Jung KI, Park CK. Pirfenidone inhibits fibrosis in foreign body reaction after glaucoma drainage device implantation. Drug Des Devel Ther 2016;10:1477-1488.
  • Inagaki Y, Okazaki I. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 2007;56:284-292.
  • Huber LC, Distler JH, Moritz F, et al. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis Rheum 2007;56:2755-2764.
  • Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268-1279.
  • Guo W, Shan B, Klingsberg RC, et al. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. Am J Physiol Lung Cell Mol Physiol 2009;297:L864-870.
  • Gregoretti I, Lee Y-M, Goodson HV. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol 2004;338:17–31.
  • Georgoulas S, Dahlmann-Noor A, Brocchini S, Khaw PT. Modulation of wound healing during and after glaucoma surgery. Prog Brain Res 2008;173:237-254.
  • Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J 2010;12:348-360.
  • Ekinci M, Cagatay HH, Ceylan E, et al. Reduction of conjunctival fibrosis after trabeculectomy using topical α-lipoic acid in rabbit eyes. J Glaucoma 2014;23:372-379.
  • DeBry PW, Perkins TW, Heatley G, et al. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 2002;120:297-300.
  • Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126:498-505.
  • Cohen JS, Greff LJ, Novack GD, Wind BE. A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures. Ophthalmology 1996;103:1934-1942.
  • Chong RS, Lee YS, Chu SWL, et al. Inhibition of monocyte chemoattractant protein 1 prevents conjunctival fibrosis in an experimental model of glaucoma filtration surgery. Invest Ophthalmol Vis Sci 2017;58:3432-3439.
  • Chen YH, Liang CM, Chen CL, et al. Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model. Acta Ophthalmol 2013;91:e506-515.
  • Addicks EM, Quigley HA, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 1983;101:795-798.